Circulating tumor cells in uveal melanoma." The needle in the haystack"

被引:0
|
作者
Grisanti, Salvatore [1 ]
Sonntag, S. R. [1 ]
Tura, S. A. [1 ]
机构
[1] Univ Lubeck, Univ Klinikum Schleswig Holstein, Klin Augenheilkunde, Ratzeburger Allee 160, D-23562 Lubeck, Germany
来源
OPHTHALMOLOGIE | 2024年 / 121卷 / 12期
关键词
Cell dissemination; Monosomy; 3; Detection methods; Metastases; Micrometastases; PROGNOSTIC-FACTORS; PERIPHERAL-BLOOD; FREE SURVIVAL; BONE-MARROW; ENUCLEATION; DISEASE; PROGRESSION; NUMBER;
D O I
10.1007/s00347-024-02136-z
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: A fundamental prerequisite for the development of clinically manifested metastases in uveal melanoma (UM) is the hematogenous dissemination of melanoma cells, which circulate in the systemic circulation, deposit in organs and can subsequently colonize the organs. Material and methods: This article presents a review of the literature on the detection of circulating tumor cells (CTC) from UM and their relevance for the clinical and pathophysiological aspects of the malignancy. Results: Since the first description of CTC in UM patients 20 years ago, only 20 articles have been published on the detection of intact CTCs in UM. Besides demonstrating the presence of CTCs in the systemic circulation, these articles give insights into the pathophysiology and chronology of CTC dissemination, the diagnostics and risk stratification of UM. Conclusion: The detection of CTC in UM has proved to be beneficial in many ways. The early time of cell dissemination and also the associated factors should lead to a rethinking in the clinical routine in the context of the fatal danger of metastases.
引用
收藏
页码:954 / 962
页数:9
相关论文
共 50 条
  • [31] Cytomorphometry as a prognostic factor for uveal and cutaneous melanoma.
    Lavinsky, F
    Pereira, F
    Correia, CP
    Carey, W
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S381 - S381
  • [32] Coexpression of vimenyin and cytokeratin un uveal melanoma.
    Correia, CP
    Rodriguez, AA
    Oliver, KM
    Deschenes, J
    Burnier, MN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S383 - S383
  • [33] Aqueous humor as a liquid biopsy for uveal melanoma.
    Kim, Mary E.
    Xu, Liya
    Peng, Chen-Ching
    Kuhn, Peter
    Hicks, James
    Berry, Jesse L.
    CANCER RESEARCH, 2021, 81 (13)
  • [34] Uveal Melanoma. Tumours Are Best Treated with Brachytherapy
    Seregard, Stefan
    OPHTHALMOLOGICA, 2014, 232 : 22 - 23
  • [35] Intratumor variability of microvessel density in uveal melanoma.
    Gaudio, P
    Egan, KM
    Tolentino, MJ
    Gragoudas, ES
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 3759 - 3759
  • [36] Fine mapping of chromosome 3 in uveal melanoma.
    Merbs, SL
    Parrella, P
    Sidransky, D
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S216 - S216
  • [37] Mutations in GNA11 in Uveal Melanoma.
    Van Raamsdonk, Catherine D.
    Griewank, Klaus G.
    Crosby, Michelle B.
    Garrido, Maria C.
    Vemula, Swapna
    Wiesner, Thomas
    Obenauf, Anna C.
    Wackernagel, Werner
    Green, Gary
    Bouvier, Nancy
    Sozen, M. Mert
    Baimukanova, Gail
    Roy, Ritu
    Heguy, Adriana
    Dolgalev, Igor
    Khanin, Raya
    Busam, Klaus
    Speicher, Michael R.
    O'Brien, Joan
    Bastian, Boris C.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2191 - 2199
  • [38] Post-brachytherapy dynamics of uveal melanoma.
    Pe'er, JJ
    Kaiserman, I
    Anteby, I
    Chowers, I
    Blumenthal, EZ
    Kliers, I
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S565 - S565
  • [39] The use of pembrolizumab for the treatment of metastatic uveal melanoma.
    Kottschade, Lisa A.
    McWilliams, Robert R.
    Markovic, Svetomir
    Block, Matthew Stephen
    Bisneto, Jose Villasboas
    Pham, Anthony QuocAnh
    Dronca, Roxana Stefania
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [40] Variates of survival for stage IV uveal melanoma.
    Rietschel, P
    Panageas, K
    Hanlon, C
    Patel, A
    Chapman, PB
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 719S - 719S